Mr. Ian Atacan reports

PHARMACIELO ANNOUNCES ANNUAL GENERAL MEETING AND INTENTION TO ISSUE INTEREST SHARES

Pharmacielo Ltd. will hold its annual general meeting of shareholders (AGM) on April 2, 2026. The record date for determining shareholders entitled to receive notice of and vote at the AGM has been set as Feb. 23, 2026.

Materials for the meeting will be filed on SEDAR+ and made available to shareholders in accordance with applicable securities laws.

Interest shares

Today, Pharmacielo also announced that it intends to issue, subject to the approval of the TSX Venture Exchange, 12,153,937 common shares of Pharmacielo, at an effective price of eight cents per interest share, in satisfaction of an aggregate of $972,317.12 in accrued semi-annual interest payments due to holders of the company's 11 per cent secured debentures.

The effective price of the interest shares was determined by dividing the cash interest otherwise payable by the number of shares issuable under each debenture, in accordance with the terms of the debentures and TSX Venture Exchange Policy 4.3, Section 3.3.

The interest shares are subject to the balance, if any, of the applicable statutory hold period under Canadian securities laws.

About Pharmacielo Ltd.

Pharmacielo is a global company, headquartered in Canada, with a focus on ethical and sustainable cultivating, processing and supply of all natural, pharmaceutical-grade medical dried cannabis flower and cannabis extracts for the natural pharmaceuticals and consumer products market. Pharmacielo's principal (and wholly owned) subsidiary is PharmaCielo Colombia Holdings S.A.S., headquartered at its cultivation and processing centre, located in Rionegro, Colombia.

We seek Safe Harbor.